International Vaccine Institute to open Africa Regional Office in Rwanda

South Korea-based International Vaccine Institute (IVI), and the Ministry of Health of Rwanda have announced that IVI wi...

February 28, 2024 | Wednesday | News
Japan's Takeda accelerates dengue vaccine access through manufacturing partnership with Biological E in India

Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...

February 27, 2024 | Tuesday | News
Korea's SK bioscience obtains WHO prequalification for typhoid conjugate vaccine

SK bioscience, a South Korea-based vaccine and biotech company, has obtained prequalification (PQ) certification from th...

February 27, 2024 | Tuesday | News
US-based VBI Vaccines sells manufacturing capabilities to China's Brii Biosciences for $33 M

US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...

February 16, 2024 | Friday | News
Experts advocate HPV Vaccination Programmes for Gynaecologic Cancer prevention in MENA region

The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...

January 30, 2024 | Tuesday | Opinion
GSK Australia announces regulatory approval of respiratory syncytial virus vaccine AREXVY

GSK Australia has received Therapeutic Goods Administration (TGA) approval of AREXVY (respiratory syncytial virus v...

January 19, 2024 | Friday | News
Zuellig Pharma & Substipharm Biologics expand access to Japanese Encephalitis vaccine across Asia

Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...

January 16, 2024 | Tuesday | News
Singapore's Duke-NUS scientists discover potential nasal COVID-19 vaccine candidate

A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...

January 10, 2024 | Wednesday | News
CEPI partners with Korean biotech startup Lemonex to advance mRNA vaccine delivery

Norway-based Coalition for Epidemic Preparedness Innovations(CEPI) has partnered with Lemonex Inc. (Lemonex), a bi...

January 5, 2024 | Friday | News
Korea gives license to Euvichol-S, simplified formulation of oral cholera vaccine

The International Vaccine Institute (IVI) and EuBiologics Co have announced the licensure for export by the Korean Minis...

January 2, 2024 | Tuesday | News
CEPI and PATH strengthen partnership to accelerate development of vaccines

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and US-based nonprofit global health organisation&nb...

December 19, 2023 | Tuesday | News
Novavax's updated COVID-19 vaccine receives emergency use authorisation in Taiwan

American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, h...

December 18, 2023 | Monday | News
Novo Nordisk Foundation commits up to $260 M to establish research and vaccine development initiative

Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...

December 18, 2023 | Monday | News
CEPI supports novel mRNA vaccine development in Korea to protect against future Disease X

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...

December 12, 2023 | Tuesday | News
DxVx plans clinical trials of cancer vaccine in Asia, including Korea and China

South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...

November 27, 2023 | Monday | News
Chulalongkorn University in Thailand supports UK-South East Asia vaccine manufacturing research hub

Thailand's Chulalongkorn University and the University of Sheffield, England, have signed an academic cooperation agreem...

November 24, 2023 | Friday | News
Korea accelerates innovations in vaccines and immunology

The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) have signed...

November 23, 2023 | Thursday | News
SK bioscience and Hilleman Laboratories to develop Zaire Ebola Virus vaccine

South Korea-based SK bioscience has entered into a development licensing agreement with Hilleman Laboratories, in Singap...

November 22, 2023 | Wednesday | News